EFFECT OF HYDROALCOHOLIC EXTRACT OF ACHYRANTHES ASPERA ON HALOPERIDOLINDUCED PARKINSON'S DISEASE IN WISTAR RATS

Chitra V; Manasa K; Mythili A; Tamilanban T; Gayathri K

doi:10.22159/ajpcr.2017.v10i9.19285

Authors

Chitra V Department of Pharmacology, SRM College of Pharmacy, SRM University, Kattankulathur â€“ 603 203, Tamil Nadu, India.
Manasa K Department of Pharmacology, SRM College of Pharmacy, SRM University, Kattankulathur â€“ 603 203, Tamil Nadu, India.
Mythili A Department of Pharmacology, SRM College of Pharmacy, SRM University, Kattankulathur â€“ 603 203, Tamil Nadu, India.
Tamilanban T Department of Pharmacology, SRM College of Pharmacy, SRM University, Kattankulathur â€“ 603 203, Tamil Nadu, India.
Gayathri K Department of Pharmacology, SRM College of Pharmacy, SRM University, Kattankulathur â€“ 603 203, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2017.v10i9.19285

Keywords:

Achyranthes aspera, Haloperidol, Catatonia behavior, Nil, Levodopa

Abstract

Â

Â Objective: Prolonged usage of neuroleptics in psychotic disorders such as schizophrenia provokes extrapyramidal symptoms that are also seen in Parkinson's disease. An attempt has been made to study the neuroprotective role of Achyranthes aspera hydroalcoholic (HA) extract on haloperidol-induced Parkinson's symptoms in Wistar rats.

Methods: The present study deals with the antiparkinson effect of HA extract of A. aspera on haloperidol (2 mg/kg intraperitoneal administration)- induced catatonia in Wistar rats. The motor coordination in case of haloperidol-treated animals was studied by performing rotarod test and hang test. Dopamine and 3,4-dihydroxyphenylacetic acid were estimated using an electrochemical detector and high-performance liquid chromatography. The antioxidant status was also assessed to know the neurotoxicity of haloperidol by estimating the levels of lipid peroxidation, superoxide dismutase, glutathione (GSH) peroxidase, and reduced GSH by performing individual assays.

Results: All these assessments were done on 24 Wistar rats which were divided into four groups (n=6). HA was administered at 200 and 400 mg/kg doses, 30 minutes before haloperidol treatment for 20 days. HA significantly (*p<0.05, **p<0.01) improved the antioxidant status.

Conclusion: The results shown that HA shows a protective role in haloperidol catalepsy and also possess antioxidant property.

Downloads

Download data is not yet available.

References

Vegeto E, Benedusi V, Maggi A. Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseases. Front Neuroendocrinol 2008;29(4):507-19.

Shibeshi W, Makonnen E, Zerihun L, Debella A. Effect of Achyranthes aspera L. on fetal abortion, uterine and pituitary weights, serum lipids and hormones. Afr Health Sci 2006;6(2):108-12.

Akhtar MS, Iqbal J. Evaluation of the hypoglycaemic effect of Achyranthes aspera in normal and alloxan-diabetic rabbits. J Ethnopharmacol 1991;31(1):49-57.

Okpaka DT. Principles of Pharmacology: A Tropical Approach. 2nd ed. London: Cambridge University Press; 1991. p. 358.

Pemminati S, Nair V, Dorababu P, Gopalakrishna HN, Pai MR. Effect of ethanolic leaf extract of Ocimum sanctum on haloperidol-induced catalepsy in albino mice. Indian J Pharmacol 2009;39(2):87-9.

Srivastava PK. Achyranthes aspera: A potent immunostimulating plant for traditional medicine. Int J Pharm Sci Res 2014;5(5):1601-11.

Jayakumar T, Sridhar MP, Bharatprasad TR, Ilayaraja M, Govindasamay S, Balasubramanian MP. Phytochemical screening and evaluation of cytotoxicity and thrombolytic properties of Achranthes aspera leaf extract. J Health Sci 2009;2:587-94.

Gupta SS, Verma SC, Ram AK, Tripati RL. Diuretic effect of the Achyranthes aspera (apamarga). Indian J Pharm 1972;4(4):208-14.

Page C, Curtis M, Sulter M, Walker M, Hoffman B. Integrated Pharmacology. 2nd ed. New York: Elsevier; 2006. p. 263-8.

Kaboyashi T, Araki T, Itoyama Y, Ohta T, Oshima Y. Effects of L-DOPA on haloperidol-Induced catalepsy in motor deficits in mice. Life Sci 1997;61(26):2529-38.

Vogel GH. Drug Discovery and Evaluation-Pharmacological Assays. 2nd ed. Germany: Springer; 2002. p. 397.

Turner RA. Screening Methods in Pharmacology. 2nd ed. London: Academic Press; 1971. p.231.

Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972;47(2):389-94.

Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47(3):469-74.

Craig CR, Stitzel RE. Modern Pharmacology with Clinical Applications. 6th ed. USA: Lippincotts Williams and Wilkins; 2004. p. 234-9.

Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984;21(2):130-2.

Polydoro M, SchrÃ¶der N, Lima MN, Caldana F, Laranja DC, Bromberg E, et al. Haloperidol- and clozapine-induced oxidative stress in the rat brain. Pharmacol Biochem Behav 2004;78(4):751-6.

Nellore J, Sahajan A, Antony D, Cynthia PP, Namasivayam SK. Proteinaceous compounds from Fragaria ananassa fruit attenuates paraquat induced Parkinson like locomotor and mitochondrial alterations in Zebrafish. Int J Pharm Pharm Sci 2015;7(6):246-51.

Tanwani H, Phadnis P, Atal S, Churihar R, Gudsurkar G. Study to evaluate the role of serotonin in Parkinsonian symptoms. Int J Pharm Pharm Sci 2016;8:209-11.

Carta M, Carlsson T, Kirik D, BjÃ¶rklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in Parkinsonian rats. Brain 2007;130(Pt 7):1819-33.